HIMVX
Price
$28.56
Change
-$0.04 (-0.14%)
Updated
Nov 13 closing price
VMVIX
Price
$67.47
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

HIMVX vs VMVIX

Header iconHIMVX vs VMVIX Comparison
Open Charts HIMVX vs VMVIXBanner chart's image
Harbor Mid Cap Value Investor
Price$28.56
Change-$0.04 (-0.14%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Investor
Price$67.47
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
HIMVX vs VMVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HIMVX vs. VMVIX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIMVX is a StrongBuy and VMVIX is a Buy.

FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 30.9B vs. HIMVX (392M). VMVIX pays higher dividends than HIMVX: VMVIX (2.03) vs HIMVX (1.06). HIMVX was incepted earlier than VMVIX: HIMVX (22 years) vs VMVIX (18 years). VMVIX is a more actively managed with annual turnover of: 22.00 vs. HIMVX (10.00). HIMVX has a lower initial minimum investment than VMVIX: HIMVX (2500) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 28.28 vs. HIMVX (26.20). VMVIX return over 5 years is better than : 48.79 vs. HIMVX (38.64).
HIMVXVMVIXHIMVX / VMVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years18 years-
Gain YTD17.40618.43894%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets392M30.9B1%
Annual Yield % from dividends1.062.0352%
Returns for 1 year26.2028.2893%
Returns for 3 years11.6214.9378%
Returns for 5 years38.6448.7979%
Returns for 10 years45.76100.4546%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRPH0.770.03
+4.39%
ProPhase Labs
U19.13-0.09
-0.47%
Unity Software
WAFD37.15-0.28
-0.75%
WaFd
TCRT2.40-0.04
-1.64%
Alaunos Therapeutics Inc.
ATRO16.49-0.38
-2.25%
Astronics Corp